Menkes disease is a dubious disease in the field of genetic metabolism, clinical performance is complex and often involves multi-systematic stress. Early identification and standardised clinical care are essential for improving prognosis. Diagnosis of the disease requires a comprehensive assessment platform including clinical performance, imaging, laboratory testing and pathological activation.
A team of authoritative experts at home and abroad can assist in providing accurate diagnosis and treatment. Individualised development of treatment plans for treatment and management of Menkes disease typically includes drug therapy, rehabilitation interventions, and regular follow-up management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat genetic metabolic diseases have been significantly improved.
Treatment requires close monitoring of therapeutic efficacy and adverse reactions and timely adjustment to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of Menkes disease. The platform serves a team of authoritative experts at home and abroad in the field of genetic metabolism linked to the China International Medical Service System, providing patients with the following services: 1.
Remote diagnosis: A team of experts reviews the medical history in advance, clarifies the diagnosis and makes recommendations; 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.